{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T01:10:01Z","timestamp":1790989801022,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T00:00:00Z","timestamp":1653868800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.canlet.2022.215735","type":"journal-article","created":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T03:34:25Z","timestamp":1652412865000},"page":"215735","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"special_numbering":"C","title":["Integrated analysis of ascites and plasma extracellular vesicles identifies a miRNA-based diagnostic signature in ovarian cancer"],"prefix":"10.1016","volume":"542","author":[{"given":"Wenyu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HyunA","family":"Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangick","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heeyeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se Ik","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngjin","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juwon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aeran","family":"Seol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheol","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny N.","family":"Dhanasekaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taejin","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7115-4021","authenticated-orcid":false,"given":"Yong Sang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2022.215735_bib1","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1158\/1055-9965.EPI-17-0290","article-title":"Recent trends in ovarian cancer incidence and relative survival in the United States by race\/ethnicity and histologic subtypes","volume":"26","author":"Park","year":"2017","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.canlet.2022.215735_bib2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.20892\/j.issn.2095-3941.2016.0084","article-title":"Epidemiology of ovarian cancer: a review","volume":"14","author":"Reid","year":"2017","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.canlet.2022.215735_bib3","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1001\/jama.2011.766","article-title":"Effect of screening on ovarian cancer mortality: the prostate, lung, colorectal and ovarian (PLCO) cancer screening randomized controlled trial","volume":"305","author":"Buys","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.canlet.2022.215735_bib4","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0140-6736(15)01224-6","article-title":"Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial","volume":"387","author":"Jacobs","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.canlet.2022.215735_bib5","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.7150\/thno.34692","article-title":"Liquid biopsy in ovarian cancer: recent advances in circulating extracellular vesicle detection for early diagnosis and monitoring progression","volume":"9","author":"Chang","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.canlet.2022.215735_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015353","article-title":"Exosomes communicate protective messages during oxidative stress; possible role of exosomal shuttle RNA","volume":"5","author":"Eldh","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2022.215735_bib7","series-title":"RNA in Extracellular Vesicles","first-page":"8","author":"Kim","year":"2017"},{"key":"10.1016\/j.canlet.2022.215735_bib8","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13045-020-00893-3","article-title":"Non-coding RNAs shuttled via exosomes reshape the hypoxic tumor microenvironment","volume":"13","author":"Wang","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.canlet.2022.215735_bib9","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41580-020-0251-y","article-title":"RNA delivery by extracellular vesicles in mammalian cells and its applications","volume":"21","author":"O'Brien","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2022.215735_bib10","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.celrep.2016.03.085","article-title":"KRAS-MEK signaling controls Ago2 sorting into exosomes","volume":"15","author":"McKenzie","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2022.215735_bib11","doi-asserted-by":"crossref","first-page":"958","DOI":"10.3892\/ijmm.2016.2488","article-title":"Role of Alix in miRNA packaging during extracellular vesicle biogenesis","volume":"37","author":"Iavello","year":"2016","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.canlet.2022.215735_bib12","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1016\/j.febslet.2015.11.036","article-title":"Commitment of Annexin A2 in recruitment of microRNAs into extracellular vesicles","volume":"589","author":"Hagiwara","year":"2015","journal-title":"FEBS Lett."},{"key":"10.1016\/j.canlet.2022.215735_bib13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12920-019-0473-z","article-title":"Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid","volume":"12","author":"Otake","year":"2019","journal-title":"BMC Med. Genom."},{"key":"10.1016\/j.canlet.2022.215735_bib14","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1038\/ncomms3980","article-title":"Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs","volume":"4","author":"Villarroya-Beltri","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2022.215735_bib15","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.celrep.2016.09.031","article-title":"The RNA-binding protein SYNCRIP is a component of the hepatocyte exosomal machinery controlling MicroRNA sorting","volume":"17","author":"Santangelo","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2022.215735_bib16","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/s41467-018-03182-3","article-title":"A cryptic RNA-binding domain mediates Syncrip recognition and exosomal partitioning of miRNA targets","volume":"9","author":"Hobor","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2022.215735_bib17","doi-asserted-by":"crossref","first-page":"993","DOI":"10.3892\/or.2017.5717","article-title":"Hypoxia- and acidosis-driven aberrations of secreted microRNAs in endometrial cancer in vitro","volume":"38","author":"Eismann","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.canlet.2022.215735_bib18","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12943-020-01199-1","article-title":"Comprehensive landscape of extracellular vesicle-derived RNAs in cancer initiation, progression, metastasis and cancer immunology","volume":"19","author":"Hu","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2022.215735_bib19","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S1470-2045(06)70939-1","article-title":"Mechanisms of transcoelomic metastasis in ovarian cancer","volume":"7","author":"Tan","year":"2006","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.canlet.2022.215735_bib20","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/cas.12987","article-title":"Ascites modulates cancer cell behavior, contributing to tumor heterogeneity in ovarian cancer","volume":"107","author":"Kim","year":"2016","journal-title":"Cancer Sci."},{"key":"10.1016\/j.canlet.2022.215735_bib21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41416-020-0875-x","article-title":"The untapped potential of ascites in ovarian cancer research and treatment","volume":"123","author":"Ford","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2022.215735_bib22","first-page":"9","article-title":"Liquid biopsy of non-plasma body fluids in non-small cell lung cancer: look closer to the tumor","author":"Durin","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.canlet.2022.215735_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/antiox9111137","article-title":"ROS-induced SIRT2 upregulation contributes to cisplatin sensitivity in ovarian cancer","volume":"9","author":"Wang","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/j.canlet.2022.215735_bib24","first-page":"12","article-title":"Proteomic discovery of biomarkers to predict prognosis of high-grade serous ovarian carcinoma","author":"Kim","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.canlet.2022.215735_bib25","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1158\/1078-0432.CCR-18-1941","article-title":"Clinical significance of extracellular vesicles in plasma from glioblastoma patients","volume":"25","author":"Osti","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2022.215735_bib26","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.biochi.2018.02.007","article-title":"Temozolomide affects extracellular vesicles released by glioblastoma cells","volume":"155","author":"Andre-Gregoire","year":"2018","journal-title":"Biochimie"},{"key":"10.1016\/j.canlet.2022.215735_bib27","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1593\/tlo.13640","article-title":"Ionizing radiation and glioblastoma exosomes: implications in tumor biology and cell migration","volume":"6","author":"Arscott","year":"2013","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.canlet.2022.215735_bib28","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41568-018-0007-6","article-title":"Organoids in cancer research","volume":"18","author":"Drost","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2022.215735_bib29","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13048-018-0458-0","article-title":"Exosomal miR-1290 is a potential biomarker of high-grade serous ovarian carcinoma and can discriminate patients from those with malignancies of other histological types","volume":"11","author":"Kobayashi","year":"2018","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.canlet.2022.215735_bib30","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.7150\/jca.30231","article-title":"Serum exosomal miRNA-145 and miRNA-200c as promising biomarkers for preoperative diagnosis of ovarian carcinomas","volume":"10","author":"Kim","year":"2019","journal-title":"J. Cancer"},{"key":"10.1016\/j.canlet.2022.215735_bib31","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jbiotec.2019.04.003","article-title":"Circulating epithelial-mesenchymal transition-associated miRNAs are promising biomarkers in ovarian cancer","volume":"297","author":"Marton","year":"2019","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.canlet.2022.215735_bib32","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.canlet.2016.12.017","article-title":"Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: a validation across two independent cohorts","volume":"388","author":"Todeschini","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2022.215735_bib33","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2174\/22115374OTY4aMzknTcVY","article-title":"The promising signatures of circulating microRNA-145 in epithelial ovarian cancer patients","volume":"9","author":"Zuberi","year":"2020","journal-title":"MicroRNA"},{"key":"10.1016\/j.canlet.2022.215735_bib34","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1007\/s00432-019-03004-z","article-title":"Malignant ascites-derived organoid (MADO) cultures for gastric cancer in vitro modelling and drug screening","volume":"145","author":"Li","year":"2019","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.canlet.2022.215735_bib35","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.lungcan.2015.11.013","article-title":"Hsa-miR-1246 and hsa-miR-1290 are associated with stemness and invasiveness of non-small cell lung cancer","volume":"91","author":"Kim","year":"2016","journal-title":"Lung Cancer"},{"key":"10.1016\/j.canlet.2022.215735_bib36","doi-asserted-by":"crossref","first-page":"11702","DOI":"10.1038\/ncomms11702","article-title":"Tumour-initiating cell-specific miR-1246 and miR-1290 expression converge to promote non-small cell lung cancer progression","volume":"7","author":"Zhang","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2022.215735_bib37","doi-asserted-by":"crossref","first-page":"11977","DOI":"10.18632\/oncotarget.24046","article-title":"miR-1290 promotes lung adenocarcinoma cell proliferation and invasion by targeting SOCS4","volume":"9","author":"Xiao","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2022.215735_bib38","article-title":"Exosomal microRNA miR-1246 induces cell motility and invasion through the regulation of DENND2D in oral squamous cell carcinoma","volume":"6","author":"Sakha","year":"2016","journal-title":"Sci Rep-Uk"},{"key":"10.1016\/j.canlet.2022.215735_bib39","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1159\/000485780","article-title":"Exosomal MicroRNA MiR-1246 promotes cell proliferation, invasion and drug resistance by targeting CCNG2 in breast cancer","volume":"44","author":"Li","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.canlet.2022.215735_bib40","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1093\/abbs\/gmz077","article-title":"Exosome-mediated transfer of miR-1290 promotes cell proliferation and invasion in gastric cancer via NKD1","volume":"51","author":"Huang","year":"2019","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"10.1016\/j.canlet.2022.215735_bib41","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.biopha.2015.10.005","article-title":"MiR-1290 promotes cancer progression by targeting nuclear factor I\/X(NFIX) in esophageal squamous cell carcinoma (ESCC)","volume":"76","author":"Mao","year":"2015","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.canlet.2022.215735_bib42","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1159\/000495328","article-title":"miRNA-1290 promotes aggressiveness in pancreatic ductal adenocarcinoma by targeting IKK1","volume":"51","author":"Ta","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.canlet.2022.215735_bib43","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/s41388-019-0996-y","article-title":"Hypoxic glioma-derived exosomes deliver microRNA-1246 to induce M2 macrophage polarization by targeting TERF2IP via the STAT3 and NF-kappaB pathways","volume":"39","author":"Qian","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2022.215735_bib44","first-page":"12","article-title":"Hypoxia-induced adaptations of miRNomes and proteomes in melanoma cells and their secreted extracellular vesicles","author":"Walbrecq","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.canlet.2022.215735_bib45","doi-asserted-by":"crossref","first-page":"15755","DOI":"10.3390\/ijms131215755","article-title":"RORalpha, a potential tumor suppressor and therapeutic target of breast cancer","volume":"13","author":"Du","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2022.215735_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102651","article-title":"MiR-18a-downregulated RORA inhibits the proliferation and tumorigenesis of glioma using the TNF-alpha-mediated NF-kappaB signaling pathway","volume":"52","author":"Jiang","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.canlet.2022.215735_bib47","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s41389-018-0089-8","article-title":"MicroRNA-transcription factor network analysis reveals miRNAs cooperatively suppress RORA in oral squamous cell carcinoma","volume":"7","author":"Zheng","year":"2018","journal-title":"Oncogenesis"},{"key":"10.1016\/j.canlet.2022.215735_bib48","first-page":"150","article-title":"Emerging role of microRNAs in disease pathogenesis and strategies for therapeutic modulation","volume":"10","author":"Mattes","year":"2008","journal-title":"Curr. Opin. Mol. Therapeut."},{"key":"10.1016\/j.canlet.2022.215735_bib49","doi-asserted-by":"crossref","first-page":"6812","DOI":"10.1158\/0008-5472.CAN-17-2142","article-title":"Emerging role of CRISPR\/Cas9 Technology for MicroRNAs editing in cancer research","volume":"77","author":"Aquino-Jarquin","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2022.215735_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13112680","article-title":"MicroRNA therapeutics in cancer: current advances and challenges","volume":"13","author":"Reda El Sayed","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.canlet.2022.215735_bib51","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1158\/0008-5472.CAN-11-3160","article-title":"Reprogramming tumor-associated dendritic cells in vivo using miRNA mimetics triggers protective immunity against ovarian cancer","volume":"72","author":"Cubillos-Ruiz","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2022.215735_bib52","doi-asserted-by":"crossref","first-page":"15093","DOI":"10.18632\/oncotarget.7618","article-title":"Therapeutic evaluation of microRNA-15a and microRNA-16 in ovarian cancer","volume":"7","author":"Dwivedi","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2022.215735_bib53","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/21691401.2018.1454931","article-title":"The role of microRNAs and nanoparticles in ovarian cancer: a review","volume":"46","author":"Kafshdooz","year":"2018","journal-title":"Artif. Cell Nanomed. Biotechnol."},{"key":"10.1016\/j.canlet.2022.215735_bib54","doi-asserted-by":"crossref","first-page":"23926","DOI":"10.1021\/acsami.9b07980","article-title":"Tumor-targeting, MicroRNA-silencing porous silicon nanoparticles for ovarian cancer therapy","volume":"11","author":"Bertucci","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383522002191?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383522002191?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T16:04:42Z","timestamp":1759593882000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383522002191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":54,"alternative-id":["S0304383522002191"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2022.215735","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrated analysis of ascites and plasma extracellular vesicles identifies a miRNA-based diagnostic signature in ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2022.215735","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"215735"}}